Difference between revisions of "Hydroxychloroquine"

From Conservapedia
Jump to navigation Jump to search
(Never-Trumpers in government and hospitals block early use of this medication, and instead either withhold it from patients entirely or delay it until the end stage of the patient's life when medications are least effective.)
(reduction in binding effect)
Line 20: Line 20:
 
According to the website ResearchGate.net: "Several studies have reported that zinc has a broad-spectrum antiviral activity against a variety of viruses. Increased intracellular Zinc concentrations inhibit RNA-dependent RNA polymerases and other proteins essential for the completion of different phases of the virus life cycle. Further, zinc also helps to maintain robust immune responses by producing cytokine and by modulation of immune cell activity."<ref>[https://www.researchgate.net/post/Is_a_combo_of_chloroquine_and_Zinc_a_cure_for_coronavirus Is a combo of chloroquine and Zinc a cure for coronavirus?]</ref>
 
According to the website ResearchGate.net: "Several studies have reported that zinc has a broad-spectrum antiviral activity against a variety of viruses. Increased intracellular Zinc concentrations inhibit RNA-dependent RNA polymerases and other proteins essential for the completion of different phases of the virus life cycle. Further, zinc also helps to maintain robust immune responses by producing cytokine and by modulation of immune cell activity."<ref>[https://www.researchgate.net/post/Is_a_combo_of_chloroquine_and_Zinc_a_cure_for_coronavirus Is a combo of chloroquine and Zinc a cure for coronavirus?]</ref>
  
 +
== Reduction in binding effect ==
 +
 +
Hydroxychlorquine reportedly "directly reduces the binding of antiphospholipid [[antibody]]–β2-glycoprotein I complexes to phospholipid bilayers":<ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518879/</ref>
 +
{{[W]e have provided clear evidence that HCQ can dissociate aPL IgG–β2GPI complexes from phospholipid bilayers. Additional studies will be needed to further define the molecular mechanism(s) for this dissociation and its possible role in modifying the APS disease process.}}
 
==See also==
 
==See also==
 
* [[Azithromycin]]
 
* [[Azithromycin]]

Revision as of 04:32, April 12, 2020

Hydroxychloroquine, azithromycin (an antibiotic) and zinc has been very effective in treating coronavirus.

Hydroxychloroqine (C18H26ClN3O), also known as hydroxychloroquine sulfate and HCQ, is a drug sold under the name Plaquenil.[1] It has been used by the physician Dr. Vladimir Zelenko as a part of successful treatment for coronavirus and was recommended for such by President Trump (see: Vladimir Zelenko's coronavirus treatment). Spefically, Dr. Zelenko used hydroxychloroqine, azithromycin (an antibiotic) and zinc as a part of his treatments to his patients.[2]

China, South Korea, and India all use hydroxychloroquine to successful combat COVID-19.

Never-Trumpers in government and hospitals block early use of this medication, and instead either withhold it from patients entirely or delay it until the end stage of the patient's life when medications are least effective.

Hydroxychloroquine and coronavirus

See also: Vladimir Zelenko's coronavirus treatment

The Food and Drug Administration (FDA) allows hydroxychloroquine to be used as an off-label coronavirus treatment.

According to WebMD.com: "The practice, called 'off-label" prescribing, is entirely legal and very common. More than one in five outpatient prescriptions written in the U.S. are for off-label therapies."[3]

Hydroxychloroquine allows zinc to penetrate the cellular wall to a larger degree.[4] Zinc is an antiviral.[5]

Zinc and coronavirus

According to the website ResearchGate.net: "Several studies have reported that zinc has a broad-spectrum antiviral activity against a variety of viruses. Increased intracellular Zinc concentrations inhibit RNA-dependent RNA polymerases and other proteins essential for the completion of different phases of the virus life cycle. Further, zinc also helps to maintain robust immune responses by producing cytokine and by modulation of immune cell activity."[6]

Reduction in binding effect

Hydroxychlorquine reportedly "directly reduces the binding of antiphospholipid antibody–β2-glycoprotein I complexes to phospholipid bilayers":[7] {{[W]e have provided clear evidence that HCQ can dissociate aPL IgG–β2GPI complexes from phospholipid bilayers. Additional studies will be needed to further define the molecular mechanism(s) for this dissociation and its possible role in modifying the APS disease process.}}

See also

References

External links